Results 81 to 90 of about 17,813 (206)

Comparison Efficacy of Topical Piroxicam Gel and Lidocaine with Intravenous Pethidine in Reducing Pain during ESWL [PDF]

open access: yes, 2011
Introduction & Objective: ESWL is a non-invasive method of breaking stones, using acoustic shock waves. Shock waves cause temporary deep visceral pain and discomfort in entry; therefore, administration of sedatives is necessary.
Moazeni-Bistgani, M.   +1 more
core   +1 more source

Khaya senegalensis inhibits piroxicam mediated gastro-toxicity in wistar rats [PDF]

open access: yesAvicenna Journal of Phytomedicine, 2014
Objective:The purpose of this study was to investigate the effects of piroxicam co-administration with ethanolic stem-bark extract of Khaya senegalensis on biomarkers of oxidative stress and gastro-toxicity in Wistar rats.
Fatima Nnawodu Ishaq   +2 more
doaj  

Optimization of diarylazines as anti-HIV agents with dramatically [PDF]

open access: yes, 2013
Non-nucleoside inhibitors of HIV-1 reverse transcriptase are reported that have ca. 100-fold greater solubility than the structurally related drugs etravirine and rilpivirine, while retaining high anti-viral activity.
Anderson, Karen S.   +4 more
core   +1 more source

Effective method for the detection of piroxicam in human plasma using HPLC

open access: yesBrazilian Oral Research, 2016
Non-steroidal anti-inflammatory drugs (NSAIDs) are widely used by the general population to alleviate inflammation and pain after oral surgeries. Piroxicam is among the most commonly used NSAIDs and excels in controlling pain, swelling, trismus and other
Adriana Maria CALVO   +7 more
doaj   +1 more source

ENHANCEMENT OF PIROXICAM INTRINSIC DISSOLUTION RATE WITH SOLID DISPERSION SYSTEM USING BETA CYCLODEXTRIN [PDF]

open access: yes
Objective: This research was aimed to increase the intrinsic dissolution rate (IDR) of piroxicam with solid dispersion system of piroxicam-betacyclodextrin (SDSPB). This system can overcome the dissolution problem of piroxicam.
Binarjo, Annas, Budiarto, Setyo
core  

Comparison between paracetamol, piroxicam, their combination, and placebo in postoperative pain management of upper limb orthopedic surgery (a randomized double blind clinical trial)

open access: yesAdvanced Biomedical Research, 2016
Background: Therapeutic superiority of a combination of Paracetamol and nonsteroidal anti-inflammatory drugs (NSAIDs) over either drug alone remains controversial. We evaluated the efficiency of a combination of Paracetamol and Piroxicam versus each drug
Gholamreza Khalili   +2 more
doaj   +1 more source

Analisis Adulterasi Jamu Pegal Linu yang Diperoleh dari Pasar di Jakarta dan Sekitarnya (Analysis Of Adulterated Jamu Pegal Linu Obtained From The Market In Jakarta) [PDF]

open access: yes, 2013
Background: “Jamu Pegal Linu” (traditional Indonesian herb for rheumatoid and gouty arthritis) is one of the mostpopular jamu products manufactured and widely consumed in the community.
Gitawati, R. (Retno)
core  

Kristalne modifikacije i profil oslobađanja piroksikama [PDF]

open access: yes, 2011
Piroxicam is a nonsteroidal anti-inflammatory drug with low aqueous solubility which exhibits polymorphism. The present study was carried out to develop polymorphs of piroxicam with enhanced solubility and dissolution rate by the crystal modification ...
A. Rajendarn   +19 more
core   +2 more sources

PREPARATION AND CHARACTERIZATION OF DERMAL FILMS CONTAINING AN ANTI- INFLAMMATORY DRUG

open access: yesZagazig Journal of Pharmaceutical Sciences, 2009
Piroxicam is a potent nonsteroidal anti-inflammatory drug associated with many side effects when taken orally. An attention was paid in this work to formulate and characterize piroxicam containing polymer films for dermal use.
Saleh Abd El-Rasoul , Sayed Auda
doaj   +1 more source

The Impact of Differential Cost Sharing of Non-Steroidal Anti-Inflammatory Agents on the Use and Costs of Analgesic Drugs [PDF]

open access: yes
OBJECTIVE: To estimate the effect of differential cost sharing (DCS) schemes for non-steroidal anti-inflammatory drugs (NSAIDs) on drug subsidy program and beneficiary expenditures.
Adrian R. Levy   +5 more
core  

Home - About - Disclaimer - Privacy